scholarly journals A phase I/II dose escalation study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

2018 ◽  
Vol 29 ◽  
pp. viii397
Author(s):  
N. Ngamphaiboon ◽  
S. Lukerak ◽  
C. Jiarpinitnun ◽  
A. Jinawath ◽  
N. Jinawath ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document